Catalyst Wire Dossier Catalyst Wire Dossier

Investigational compound for anemia in CKD

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational compound for anemia in CKD, covering 2013-11-11 to 2013-11-11. Get the full timeline:

Most recent: Clinical Trial Update: Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia [Phase 2]

See pricing